Insider sale
DYNE THERAPEUTICS, INC.
$1.08M
59.84K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 59.84K shares of DYNE THERAPEUTICS, INC. valued at approximately $1.08M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/28/2026ACC: 0001628280-26-027980
10% Owner
Since Dec 2022
59.84K
Shares to sell
$1.08M
Approx. market value
59.84K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
59.84KTotal acquired59.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 59.84K | — |
| Total | 59.84K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
59.84K
Market value
$1.08M
4/28/2026
Total
Units
59.84K
Value
$1.08M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/28/2026 | 59.84K | $1.08M | Nasdaq | Planned |
| Total | 59.84K | $1.08M | ||